{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:30:22Z","timestamp":1789907422365,"version":"4.0.1"},"reference-count":0,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2013.00078","type":"journal-article","created":{"date-parts":[[2013,6,21]],"date-time":"2013-06-21T10:17:20Z","timestamp":1371809840000},"source":"Crossref","is-referenced-by-count":20,"title":["Proton-dependent inhibition of the cardiac sodium channel Nav1.5 by ranolazine"],"prefix":"10.3389","volume":"4","author":[{"given":"S.","family":"Sokolov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. H.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Rajamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. C.","family":"Ruben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2013]]},"container-title":["Frontiers in Pharmacology"],"original-title":[],"deposited":{"date-parts":[[2015,2,18]],"date-time":"2015-02-18T19:48:52Z","timestamp":1424288932000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2013.00078\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":0,"URL":"https:\/\/doi.org\/10.3389\/fphar.2013.00078","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}